A hightyinsulin-resistant,56-year-old man withTvpe2diabeteshas beenakinq200unitstotaudaily doseof
subcutaneousinsuuin perdavHisweiahtisincreasinaandhiscontrouworsenina.withanHbAlcof76
mmoumot(9.1%).Hewishestodiscuss addingpioglitazometohisreqimenashehasread thattmay help
reduce hisinsulin requirement
Whichofthefoowinq statements best describes piogtitazone therapy?
Pioqlitazonecauses heartfailureby exerting adirecttoxiceffect onthemyocardium
Pioqlitazoneisassociated withweiaht Ioss
Pioqtitazonehasnoeffect onbonemineraldensity
Heartfailurecan be precipitated in somepatients takinqglitazonesduetofuuidretention
Pioqlitazoneactsprimarity atthesiteoftheperoxisomeproliferator-activated receptor aloha(PPAR-
a)receptor
@1MINNDOCRINE
